<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Genet.</journal-id>
<journal-title>Frontiers in Genetics</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Genet.</abbrev-journal-title>
<issn pub-type="epub">1664-8021</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1509769</article-id>
<article-id pub-id-type="doi">10.3389/fgene.2024.1509769</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Genetics</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Gene expression ranking change based single sample pre-disease state detection</article-title>
<alt-title alt-title-type="left-running-head">Bao et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fgene.2024.1509769">10.3389/fgene.2024.1509769</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Bao</surname>
<given-names>Zhenshen</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1642262/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Xianbin</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/934898/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xu</surname>
<given-names>Peng</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/963034/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zan</surname>
<given-names>Xiangzhen</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2899541/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>School of Information Engineering</institution>, <institution>Taizhou University</institution>, <addr-line>Taizhou</addr-line>, <addr-line>Jiangsu</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>School of Computer and Big Data Science</institution>, <institution>Jiujiang University</institution>, <addr-line>Jiujiang</addr-line>, <addr-line>Jiangxi</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Institute of computational science and technology</institution>, <institution>Guangzhou University</institution>, <addr-line>Guangzhou</addr-line>, <addr-line>Guangdong</addr-line>, <country>China</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>School of Cultural and Creative Trade</institution>, <institution>Shenzhen Pengcheng Technician College</institution>, <addr-line>Shenzhen</addr-line>, <addr-line>Guangdong</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/757380/overview">Wanjun Gu</ext-link>, Nanjing University of Chinese Medicine, China</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2025832/overview">Mingjing Wang</ext-link>, Wenzhou Institute of Technology, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1097282/overview">Xiang Li</ext-link>, Xiamen University, China</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Zhenshen Bao, <email>bzsbao@163.com</email>; Xiangzhen Zan, <email>xiangcheng2436@163.com</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>04</day>
<month>12</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1509769</elocation-id>
<history>
<date date-type="received">
<day>11</day>
<month>10</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>18</day>
<month>11</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Bao, Li, Xu and Zan.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Bao, Li, Xu and Zan</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Introduction</title>
<p>To prevent disease, it is of great importance to detect the critical point (pre-disease state) when the biological system abruptly transforms from normal to disease state. However, rapid and accurate pre-disease state detection is still a challenge when there is only a single sample available. The state transition of the biological system is driven by the variation in regulations between genes.</p>
</sec>
<sec>
<title>Methods</title>
<p>In this study, we propose a rapid single-sample pre-disease state-identifying method based on the change in gene expression ranking, which can reflect the coordinated shifts between genes, that is, S-PCR. The R codes of S-PCR can be accessed at <ext-link ext-link-type="uri" xlink:href="https://github.com/ZhenshenBao/S-PCR">https://github.com/ZhenshenBao/S-PCR</ext-link>.</p>
</sec>
<sec>
<title>Results</title>
<p>This model-free method is validated by the successful identification of pre-disease state for both simulated and five real datasets. The functional analyses of the pre-disease state-related genes identified by S-PCR also demonstrate the effectiveness of this computational approach. Furthermore, the time efficiency of S-PCR is much better than that of its peers.</p>
</sec>
<sec>
<title>Discussion</title>
<p>Hence, the proposed S-PCR approach holds immense potential for clinical applications in personalized disease diagnosis.</p>
</sec>
</abstract>
<kwd-group>
<kwd>pre-disease state</kwd>
<kwd>state transition</kwd>
<kwd>single sample</kwd>
<kwd>ranking change</kwd>
<kwd>personalized disease diagnosis</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Computational Genomics</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>The biological system may undergo sudden deterioration during the progression of a complex disease (<xref ref-type="bibr" rid="B39">Venegas et al., 2005</xref>; <xref ref-type="bibr" rid="B27">McSharry et al., 2003</xref>), which conforms to the bifurcation and critical slowing down theory. Based on this feature, Chen et al. divvied the progression of complex disease into three states: a normal state, a disease state, and a pre-disease state (<xref ref-type="bibr" rid="B5">Chen et al., 2012</xref>; <xref ref-type="bibr" rid="B24">Liu et al., 2012</xref>). When the system is in the normal state, it is stable, under control, and with high resilience. When the system is in the disease state, it is also stable but in deterioration. When the system is in the pre-disease state, it is unstable and easily revised to the normal state with appropriate intervention but may transform into the deteriorated disease state without intervention. Thus, it is imperative to identify such pre-disease states to signal the upcoming disease and take suitable interventions to prevent the disease.</p>
<p>High-throughput technologies enable us to observe the expression of thousands of genes in a single sample at the same time, which makes it possible to measure the long-term dynamics of the biological system. However, the pre-disease state is defined as the limit of the normal state (<xref ref-type="bibr" rid="B1">Achiron et al., 2010</xref>); thus, the mean gene expression of the pre-disease state is similar to that of the normal state. Hence, it is a challenge to accurately detect the pre-disease state as the early warning signal for the disease state <italic>via</italic> time series gene expression data. To solve this problem, Chen et al. proposed a model-free method called the dynamic network biomarker (DNB), which selects a small group of genes using three statistical measurements: the average Pearson&#x2019;s correlation coefficients (PCCs) of these genes significantly increase, the average PCCs of these genes between this group and any other significantly decrease, and the average standard deviations (SDs) of these selected genes significantly increase (<xref ref-type="bibr" rid="B5">Chen et al., 2012</xref>; <xref ref-type="bibr" rid="B24">Liu et al., 2012</xref>). The implementation of these measurements needs multiple measures for an individual. However, clinical experiments can usually provide only a single sample for an individual, which limits the clinical application of the DNB approach. Therefore, there is an urgent requirement to develop methods to identify the pre-disease state as early warning signals for disease using the clinical single-sample dataset. Recently, inspired by the DNB method, many single-sample suitable methods have been proposed. These methods can be divvied into two classes. The first category of methods is mainly based on the network and entropy, for example, DNB-s (<xref ref-type="bibr" rid="B25">Liu et al., 2014</xref>), iENA (<xref ref-type="bibr" rid="B47">Yu et al., 2017</xref>), SLE (<xref ref-type="bibr" rid="B23">Liu et al., 2020</xref>), SNE (<xref ref-type="bibr" rid="B9">Han et al., 2020</xref>), SSP (<xref ref-type="bibr" rid="B16">Huo et al., 2022</xref>), DNRS (<xref ref-type="bibr" rid="B50">Zhong et al., 2022</xref>), SNPE (<xref ref-type="bibr" rid="B49">Zhong et al., 2023</xref>), and ERE (<xref ref-type="bibr" rid="B12">Hong et al., 2024</xref>; <xref ref-type="bibr" rid="B4">Bao et al., 2022</xref>; <xref ref-type="bibr" rid="B15">Huo et al., 2023</xref>). The second category of methods is gene expression distribution-based methods, which focus on gene expression distribution differences between normal and pre-disease states, such as sKLD (<xref ref-type="bibr" rid="B51">Zhong et al., 2020</xref>) and sJSD (<xref ref-type="bibr" rid="B44">Yan et al., 2021</xref>). These methods have successfully identified the pre-disease state. However, due to the application of complex biological networks and the distribution comparison for thousands of genes, the application of these methods remains limited. The running time of such a method should be as less as possible for the timely treatment to reverse the state of biological systems in clinical practice. Therefore, developing a rapid and accurate method to detect the pre-disease state is still an open problem.</p>
<p>According to the DNB theory (<xref ref-type="bibr" rid="B5">Chen et al., 2012</xref>; <xref ref-type="bibr" rid="B24">Liu et al., 2012</xref>), the expression of DNBs highly fluctuates and is highly associated with each other at the pre-disease state. In a biological system, the huge changes in the expression rankings of two genes not only signify a significant alteration in their expression patterns but also imply coordinated shifts in their expressions, revealing a close interplay between the two genes (<xref ref-type="bibr" rid="B37">Subramanian et al., 2005</xref>). Thus, the genes with significant changes in expression ranking also highly interact with each other. Specifically, the genes with huge changes in their expression value and ranking can be considered DNBs, which are the outcome of the underlying system (<xref ref-type="bibr" rid="B25">Liu et al., 2014</xref>). In this study, we propose a rapid model-free single-sample pre-disease state-identifying method based on the change in gene expression ranking, that is, S-PCR. The results of both simulation and real datasets demonstrate that the proposed S-PCR can detect the early warning signals before the system reaches a critical transition/pre-disease state. The results of the functional analysis for the two influenza virus infections and three cancer datasets indicate that the genes selected by S-PCR are highly associated with the development of diseases. Furthermore, benefitting from gene expression ranking while accurately detecting the pre-disease state, S-PCR achieves faster computational speed than other methods. Hence, the proposed approach holds immense potential for clinical applications as it enables the fast identification of individual-specific states from a single sample, thereby facilitating personalized disease prediction.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and methods</title>
<sec id="s2-1">
<title>Algorithm to detect the pre-disease state using S-PCR</title>
<p>According to the DNB theory (<xref ref-type="bibr" rid="B5">Chen et al., 2012</xref>; <xref ref-type="bibr" rid="B24">Liu et al., 2012</xref>), when the system is close to the pre-disease state, there is a group of highly related genes (DNBs) whose expressions widely fluctuate. Thus, to determine whether the sample of a time point is in the pre-disease state, we should identify whether such a set of DNBs exists at this time point. For a time point, S-PCR combines the change in the expression value and ranking. The change in the gene expression value used in S-PCR is to identify expression fluctuating signals of DNBs. The change in gene expression ranking is used to amplify such signals and seek the set of DNBs. The pre-disease state in S-PCR is detected by the following procedures (see <xref ref-type="fig" rid="F1">Figure 1</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Schematic illustration of S-PCR. Given a number of normal samples to calculate the baseline data, S-PCR is calculated based on a single sample from any individual. Specifically, the ranking of all genes for both the baseline sample and the to-be-determined single sample is calculated. For each gene, the local ranking score is calculated by combining the expression and ranking changes. Given the time-course samples from an individual, the early warning signal for the pre-disease state can be detected through the significant increase in the ranking score.</p>
</caption>
<graphic xlink:href="fgene-15-1509769-g001.tif"/>
</fig>
<p>Given <italic>n</italic> normal samples which are all in the normal state, the expression value <inline-formula id="inf1">
<mml:math id="m1">
<mml:mrow>
<mml:msubsup>
<mml:mi>E</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>b</mml:mi>
</mml:msubsup>
</mml:mrow>
</mml:math>
</inline-formula> of a gene <inline-formula id="inf2">
<mml:math id="m2">
<mml:mrow>
<mml:msub>
<mml:mi>g</mml:mi>
<mml:mi>i</mml:mi>
</mml:msub>
</mml:mrow>
</mml:math>
</inline-formula> at the time point <italic>baseline</italic> is calculated as <xref ref-type="disp-formula" rid="e1">Formula 1</xref>.<disp-formula id="e1">
<mml:math id="m3">
<mml:mrow>
<mml:msubsup>
<mml:mi>E</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>b</mml:mi>
</mml:msubsup>
<mml:mo>&#x3d;</mml:mo>
<mml:mi>m</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>n</mml:mi>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="&#x7c;">
<mml:mrow>
<mml:msubsup>
<mml:mi>E</mml:mi>
<mml:mi>i</mml:mi>
<mml:mn>1</mml:mn>
</mml:msubsup>
<mml:mo>,</mml:mo>
<mml:msubsup>
<mml:mi>E</mml:mi>
<mml:mi>i</mml:mi>
<mml:mn>2</mml:mn>
</mml:msubsup>
<mml:mo>,</mml:mo>
<mml:mo>&#x22ef;</mml:mo>
<mml:mo>,</mml:mo>
<mml:msubsup>
<mml:mi>E</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>n</mml:mi>
</mml:msubsup>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mo>,</mml:mo>
</mml:mrow>
</mml:math>
<label>(1)</label>
</disp-formula>where <inline-formula id="inf3">
<mml:math id="m4">
<mml:mrow>
<mml:msubsup>
<mml:mi>E</mml:mi>
<mml:mi>i</mml:mi>
<mml:mn>1</mml:mn>
</mml:msubsup>
<mml:mo>,</mml:mo>
<mml:msubsup>
<mml:mi>E</mml:mi>
<mml:mi>i</mml:mi>
<mml:mn>2</mml:mn>
</mml:msubsup>
<mml:mo>,</mml:mo>
<mml:mo>&#x22ef;</mml:mo>
<mml:mo>,</mml:mo>
<mml:msubsup>
<mml:mi>E</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>n</mml:mi>
</mml:msubsup>
</mml:mrow>
</mml:math>
</inline-formula> are the expression values of gene <inline-formula id="inf4">
<mml:math id="m5">
<mml:mrow>
<mml:msub>
<mml:mi>g</mml:mi>
<mml:mi>i</mml:mi>
</mml:msub>
</mml:mrow>
</mml:math>
</inline-formula> in the <italic>n</italic> normal samples.</p>
<p>For a time point <italic>t</italic>, the expression change <inline-formula id="inf5">
<mml:math id="m6">
<mml:mrow>
<mml:mo>&#x394;</mml:mo>
<mml:msubsup>
<mml:mi>E</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>t</mml:mi>
</mml:msubsup>
</mml:mrow>
</mml:math>
</inline-formula> of a gene <inline-formula id="inf6">
<mml:math id="m7">
<mml:mrow>
<mml:msub>
<mml:mi>g</mml:mi>
<mml:mi>i</mml:mi>
</mml:msub>
</mml:mrow>
</mml:math>
</inline-formula> is calculated as <xref ref-type="disp-formula" rid="e2">Formula 2</xref>.<disp-formula id="e2">
<mml:math id="m8">
<mml:mrow>
<mml:mo>&#x394;</mml:mo>
<mml:msubsup>
<mml:mi>E</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>t</mml:mi>
</mml:msubsup>
<mml:mo>&#x3d;</mml:mo>
<mml:mrow>
<mml:mfenced open="|" close="|" separators="&#x7c;">
<mml:mrow>
<mml:msubsup>
<mml:mi>E</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>t</mml:mi>
</mml:msubsup>
<mml:mo>&#x2212;</mml:mo>
<mml:msubsup>
<mml:mi>E</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>b</mml:mi>
</mml:msubsup>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mo>,</mml:mo>
</mml:mrow>
</mml:math>
<label>(2)</label>
</disp-formula>where <inline-formula id="inf7">
<mml:math id="m9">
<mml:mrow>
<mml:msubsup>
<mml:mi>E</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>t</mml:mi>
</mml:msubsup>
</mml:mrow>
</mml:math>
</inline-formula> and <inline-formula id="inf8">
<mml:math id="m10">
<mml:mrow>
<mml:msubsup>
<mml:mi>E</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>b</mml:mi>
</mml:msubsup>
</mml:mrow>
</mml:math>
</inline-formula> are the expression values of gene <inline-formula id="inf9">
<mml:math id="m11">
<mml:mrow>
<mml:msub>
<mml:mi>g</mml:mi>
<mml:mi>i</mml:mi>
</mml:msub>
</mml:mrow>
</mml:math>
</inline-formula> at the time point <italic>t</italic> and baseline, respectively. Then, the expression ranking change <inline-formula id="inf10">
<mml:math id="m12">
<mml:mrow>
<mml:mo>&#x394;</mml:mo>
<mml:msubsup>
<mml:mi>R</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>t</mml:mi>
</mml:msubsup>
</mml:mrow>
</mml:math>
</inline-formula> of that gene at the time point <italic>t</italic> is calculated as <xref ref-type="disp-formula" rid="e3">Formula 3</xref>.<disp-formula id="e3">
<mml:math id="m13">
<mml:mrow>
<mml:mo>&#x394;</mml:mo>
<mml:msubsup>
<mml:mi>R</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>t</mml:mi>
</mml:msubsup>
<mml:mo>&#x3d;</mml:mo>
<mml:mrow>
<mml:mfenced open="|" close="|" separators="&#x7c;">
<mml:mrow>
<mml:msubsup>
<mml:mi>R</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>t</mml:mi>
</mml:msubsup>
<mml:mo>&#x2212;</mml:mo>
<mml:msubsup>
<mml:mi>R</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>b</mml:mi>
</mml:msubsup>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mo>,</mml:mo>
</mml:mrow>
</mml:math>
<label>(3)</label>
</disp-formula>where <inline-formula id="inf11">
<mml:math id="m14">
<mml:mrow>
<mml:msubsup>
<mml:mi>R</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>t</mml:mi>
</mml:msubsup>
</mml:mrow>
</mml:math>
</inline-formula> and <inline-formula id="inf12">
<mml:math id="m15">
<mml:mrow>
<mml:msubsup>
<mml:mi>R</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>b</mml:mi>
</mml:msubsup>
</mml:mrow>
</mml:math>
</inline-formula> are the expression ranking of gene <inline-formula id="inf13">
<mml:math id="m16">
<mml:mrow>
<mml:msub>
<mml:mi>g</mml:mi>
<mml:mi>i</mml:mi>
</mml:msub>
</mml:mrow>
</mml:math>
</inline-formula> at the time point <italic>t</italic> and baseline, respectively. The local score <inline-formula id="inf14">
<mml:math id="m17">
<mml:mrow>
<mml:msubsup>
<mml:mi>S</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>t</mml:mi>
</mml:msubsup>
</mml:mrow>
</mml:math>
</inline-formula> of gene <inline-formula id="inf15">
<mml:math id="m18">
<mml:mrow>
<mml:msub>
<mml:mi>g</mml:mi>
<mml:mi>i</mml:mi>
</mml:msub>
</mml:mrow>
</mml:math>
</inline-formula> at the time point <italic>t</italic> can be gained by combining the expression change <inline-formula id="inf16">
<mml:math id="m19">
<mml:mrow>
<mml:mo>&#x394;</mml:mo>
<mml:msubsup>
<mml:mi>E</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>t</mml:mi>
</mml:msubsup>
</mml:mrow>
</mml:math>
</inline-formula> and expression ranking change <inline-formula id="inf17">
<mml:math id="m20">
<mml:mrow>
<mml:mo>&#x394;</mml:mo>
<mml:msubsup>
<mml:mi>R</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>t</mml:mi>
</mml:msubsup>
</mml:mrow>
</mml:math>
</inline-formula>, as <xref ref-type="disp-formula" rid="e4">Formula 4</xref> shown.<disp-formula id="e4">
<mml:math id="m21">
<mml:mrow>
<mml:msubsup>
<mml:mi>S</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>t</mml:mi>
</mml:msubsup>
<mml:mo>&#x3d;</mml:mo>
<mml:mo>&#x394;</mml:mo>
<mml:msubsup>
<mml:mi>E</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>t</mml:mi>
</mml:msubsup>
<mml:mo>&#xb7;</mml:mo>
<mml:mo>&#x394;</mml:mo>
<mml:msubsup>
<mml:mi>R</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>t</mml:mi>
</mml:msubsup>
<mml:mo>.</mml:mo>
</mml:mrow>
</mml:math>
<label>(4)</label>
</disp-formula>
</p>
<p>The genes with coordinated shifts in their expressions may have close interplays (<xref ref-type="bibr" rid="B37">Subramanian et al., 2005</xref>). Furthermore, the DNBs are always a little number of genes with huge change in their expressions and closely interact with each other (<xref ref-type="bibr" rid="B5">Chen et al., 2012</xref>; <xref ref-type="bibr" rid="B24">Liu et al., 2012</xref>). Thus, the system state at time point <italic>t</italic> can be represented as the score <inline-formula id="inf18">
<mml:math id="m22">
<mml:mrow>
<mml:msup>
<mml:mi>S</mml:mi>
<mml:mi>t</mml:mi>
</mml:msup>
</mml:mrow>
</mml:math>
</inline-formula>, which is calculated based on the top <italic>m</italic> (<italic>m</italic> &#x3d; 50) genes with the largest score <inline-formula id="inf19">
<mml:math id="m23">
<mml:mrow>
<mml:msubsup>
<mml:mi>S</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>t</mml:mi>
</mml:msubsup>
</mml:mrow>
</mml:math>
</inline-formula>, as <xref ref-type="disp-formula" rid="e5">Formula 5</xref> shown.<disp-formula id="e5">
<mml:math id="m24">
<mml:mrow>
<mml:msup>
<mml:mi>S</mml:mi>
<mml:mi>t</mml:mi>
</mml:msup>
<mml:mo>&#x3d;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mn>1</mml:mn>
</mml:mrow>
<mml:mrow>
<mml:mi>m</mml:mi>
</mml:mrow>
</mml:mfrac>
<mml:mstyle displaystyle="true">
<mml:munderover>
<mml:mo>&#x2211;</mml:mo>
<mml:mrow>
<mml:mi>i</mml:mi>
<mml:mo>&#x3d;</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
<mml:mi>m</mml:mi>
</mml:munderover>
</mml:mstyle>
<mml:mfrac>
<mml:mrow>
<mml:msubsup>
<mml:mi>S</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>t</mml:mi>
</mml:msubsup>
</mml:mrow>
<mml:mrow>
<mml:mi>N</mml:mi>
</mml:mrow>
</mml:mfrac>
<mml:mo>,</mml:mo>
</mml:mrow>
</mml:math>
<label>(5)</label>
</disp-formula>where <italic>N</italic> is the total number of genes measured for each time point of a single sample. To better seek the early warning signal for the pre-disease state, the ranking score <inline-formula id="inf20">
<mml:math id="m25">
<mml:mrow>
<mml:mo>&#x394;</mml:mo>
<mml:msup>
<mml:mi>S</mml:mi>
<mml:mi>t</mml:mi>
</mml:msup>
</mml:mrow>
</mml:math>
</inline-formula> is calculated from the score <inline-formula id="inf21">
<mml:math id="m26">
<mml:mrow>
<mml:msup>
<mml:mi>S</mml:mi>
<mml:mi>t</mml:mi>
</mml:msup>
</mml:mrow>
</mml:math>
</inline-formula> for the time point <italic>t</italic>, as <xref ref-type="disp-formula" rid="e6">Formula 6</xref> shown.<disp-formula id="e6">
<mml:math id="m27">
<mml:mrow>
<mml:mo>&#x394;</mml:mo>
<mml:msup>
<mml:mi>S</mml:mi>
<mml:mi>t</mml:mi>
</mml:msup>
<mml:mo>&#x3d;</mml:mo>
<mml:mrow>
<mml:mfenced open="|" close="|" separators="&#x7c;">
<mml:mrow>
<mml:msup>
<mml:mi>S</mml:mi>
<mml:mi>t</mml:mi>
</mml:msup>
<mml:mo>&#x2212;</mml:mo>
<mml:msup>
<mml:mi>S</mml:mi>
<mml:mn>0</mml:mn>
</mml:msup>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mo>,</mml:mo>
</mml:mrow>
</mml:math>
<label>(6)</label>
</disp-formula>where <inline-formula id="inf22">
<mml:math id="m28">
<mml:mrow>
<mml:msup>
<mml:mi>S</mml:mi>
<mml:mn>0</mml:mn>
</mml:msup>
</mml:mrow>
</mml:math>
</inline-formula> is the ranking score of the initial time point, which is the first time point after the <italic>baseline</italic>.</p>
<p>When the system is near the pre-disease state, the two measures <inline-formula id="inf23">
<mml:math id="m29">
<mml:mrow>
<mml:mo>&#x394;</mml:mo>
<mml:msubsup>
<mml:mi>E</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>t</mml:mi>
</mml:msubsup>
</mml:mrow>
</mml:math>
</inline-formula> and <inline-formula id="inf24">
<mml:math id="m30">
<mml:mrow>
<mml:mo>&#x394;</mml:mo>
<mml:msubsup>
<mml:mi>R</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>t</mml:mi>
</mml:msubsup>
</mml:mrow>
</mml:math>
</inline-formula> of these DNB biomolecules will suddenly increase. Then, the ranking score <inline-formula id="inf25">
<mml:math id="m31">
<mml:mrow>
<mml:mo>&#x394;</mml:mo>
<mml:msup>
<mml:mi>S</mml:mi>
<mml:mi>t</mml:mi>
</mml:msup>
</mml:mrow>
</mml:math>
</inline-formula> will sharply increase accordingly. Thus, the significant increase in the ranking scores for an individual can be considered an early warning signal for the pre-disease state and help understand the significantly collective fluctuating behaviors of genes in the pre-disease state.</p>
</sec>
<sec id="s2-2">
<title>Determination of the threshold for the detection of the pre-disease state</title>
<p>To identify the pre-disease state, the determination of the threshold <inline-formula id="inf26">
<mml:math id="m32">
<mml:mrow>
<mml:mi>&#x3b8;</mml:mi>
</mml:mrow>
</mml:math>
</inline-formula> for the ranking scores <inline-formula id="inf27">
<mml:math id="m33">
<mml:mrow>
<mml:mo>&#x394;</mml:mo>
<mml:msup>
<mml:mi>S</mml:mi>
<mml:mi>t</mml:mi>
</mml:msup>
</mml:mrow>
</mml:math>
</inline-formula> plays an important role. The threshold <inline-formula id="inf28">
<mml:math id="m34">
<mml:mrow>
<mml:mi>&#x3b8;</mml:mi>
</mml:mrow>
</mml:math>
</inline-formula> is calculated from the scores of normal samples, as follows:<list list-type="simple">
<list-item>
<p>Step 1: calculating the ranking scores <inline-formula id="inf29">
<mml:math id="m35">
<mml:mrow>
<mml:mo>&#x394;</mml:mo>
<mml:msup>
<mml:mi>S</mml:mi>
<mml:mi>t</mml:mi>
</mml:msup>
</mml:mrow>
</mml:math>
</inline-formula> for all normal samples.</p>
</list-item>
<list-item>
<p>Step 2: normalizing the ranking scores of all normal samples in a dataset to z-scores using the mean and standard deviation of these ranking scores.</p>
</list-item>
<list-item>
<p>Step 3: assuming that these z-scores follow a standard normal distribution, the value corresponding to the upper 0.05 is set as the threshold <inline-formula id="inf30">
<mml:math id="m36">
<mml:mrow>
<mml:mi>&#x3b8;</mml:mi>
</mml:mrow>
</mml:math>
</inline-formula> of the ranking scores for detecting the pre-disease state.</p>
</list-item>
</list>
</p>
</sec>
<sec id="s2-3">
<title>Data processing and functional analysis</title>
<p>To show the utility of S-PCR, a simulated gene regulatory network with 18 genes was used, as shown in <xref ref-type="fig" rid="F2">Figure 2A</xref>. Such a network follows the Michaelis&#x2013;Menten form and is a classical model for studying non-linear biological processes (<xref ref-type="bibr" rid="B35">Srinivasan, 2022</xref>). A detailed description of the network characterized by a set of 18 stochastic differential equations in Michaelis&#x2013;Menten form was provided by <xref ref-type="bibr" rid="B50">Zhong et al. (2022)</xref>. Then, the numeric simulation dataset was generated from the network based on a parameter <italic>q</italic> varying from &#x2212;0.4 to 0.2 and <italic>q</italic> &#x3d; 0 as the critical point (<xref ref-type="bibr" rid="B50">Zhong et al., 2022</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Performance of the proposed method of the simulated dataset. <bold>(A)</bold> A 18-node regulatory network. <bold>(B)</bold> Curve of the ranking score.</p>
</caption>
<graphic xlink:href="fgene-15-1509769-g002.tif"/>
</fig>
<p>Two real-time course gene expression datasets are obtained from the GEO database (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE30550">https://www.ncbi.nlm.nih.gov/geo/</ext-link>), including influenza virus H3N2 infection dataset GSE30550 and H1N1 infection dataset GSE52428 (<xref ref-type="bibr" rid="B13">Huang et al., 2011</xref>; <xref ref-type="bibr" rid="B43">Woods et al., 2013</xref>). Each gene is mapped by multiple probes, and the average value of these probes is used as the gene expression. The probes without the corresponding NCBI Entrez gene symbol are discarded. Three tumor disease datasets from the TCGA database (<ext-link ext-link-type="uri" xlink:href="http://cancergenome.nih.gov">http://cancergenome.nih.gov</ext-link>), namely, breast cancer (BRCA), esophageal carcinoma (ESCA), and rectum adenocarcinoma (READ), are composed of both tumor and tumor-adjacent samples. The tumor samples are grouped into different stages according to the stage information of TCGA, and the samples lacking corresponding information are ignored. <xref ref-type="table" rid="T1">Table 1</xref> lists the detailed information of the five datasets.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Details of the real datasets.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center">Dataset</th>
<th align="center">Hour/stage</th>
<th align="center">Subject</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="center">GSE30550</td>
<td align="left">Baseline, 0, 5, 12, 21, 29, 36, 45, 53, 60, 69, 77, 84, 93, 101, and 108</td>
<td align="center">Sx:9/Asx:8</td>
</tr>
<tr>
<td align="center">GSE52428</td>
<td align="left">Baseline, 0, 5, 12, 21.5, 29, 36, 45.5, 53, 60, 69.5, 77, 84, 93.5, 101, and 108</td>
<td align="center">Sx:9/Asx:15</td>
</tr>
<tr>
<td align="center">BRCA</td>
<td align="left">I, IA, IB, II, IIA, IIB, III, IIIA, IIIB, IIIC, IV, and X</td>
<td align="center">-</td>
</tr>
<tr>
<td align="center">ESCA</td>
<td align="left">I, IA, IB, II, IIA, IIB, III, IIIA, IIIB, IIIC, IV, IVA, and IVB</td>
<td align="center">-</td>
</tr>
<tr>
<td align="center">READ</td>
<td align="left">I, II, IIA, IIB, IIC, III, IIIA, IIIB, IIIC, IV, and IVA</td>
<td align="center">-</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Sx, symptomatic subjects; Asx, asymptomatic subjects.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>For the five real datasets, the top 5% genes with the largest ranking scores at the early warning signal appearing the time point are selected as candidate signaling genes. Functional analyses are carried out using GO term enrichment and KEGG pathway analysis based on these genes to find the early biological features of diseases. The GO term enrichment analysis is carried out using the web analysis tool DAVID (<ext-link ext-link-type="uri" xlink:href="https://david.ncifcrf.gov/">https://david.ncifcrf.gov/</ext-link>) (<xref ref-type="bibr" rid="B34">Sherman et al., 2022</xref>; <xref ref-type="bibr" rid="B14">Huang da et al., 2009</xref>). KEGG pathway analysis is performed using the key pathways in the Kyoto Encyclopedia of Genes and Genomes database (<ext-link ext-link-type="uri" xlink:href="https://www.kegg.jp/">https://www.kegg.jp</ext-link>) (<xref ref-type="bibr" rid="B20">Kanehisa et al., 2024</xref>). Gene analysis is performed based on the GeneCards database (<ext-link ext-link-type="uri" xlink:href="https://www.genecards.org/">https://www.genecards.org/</ext-link>).</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<p>The theoretical background and computational algorithm of S-PCR were delineated in the preceding section. To demonstrate the effectiveness of S-PCR, we implemented it on a simulated dataset, two influenza infection datasets, and three cancer datasets. The detailed description of these datasets is provided in the previous section. For all datasets, the proposed S-PCR successfully detected the early warning signals for critical points, which validated the effectiveness of our method in quantifying critical points just before critical transitions into irreversible disease states. In this process, some genes with high ranking scores in the pre-disease state were selected as candidate signaling genes for further analysis. To further validate the performance of our method, we compared it with the following peer methods: SLE (<xref ref-type="bibr" rid="B23">Liu et al., 2020</xref>) and sJSD (<xref ref-type="bibr" rid="B44">Yan et al., 2021</xref>), which are the representative methods in the two classes of pre-disease state prediction. In addition, the function of the expression ranking change was validated in the following result.</p>
<sec id="s3-1">
<title>Validation based on numerical simulation</title>
<p>The numerical simulation dataset generated from a classical 18-node regulatory network (<xref ref-type="fig" rid="F2">Figure 2A</xref>), which was represented in the Michaelis&#x2013;Menten form, is used to demonstrate the performance of the proposed method (<xref ref-type="bibr" rid="B50">Zhong et al., 2022</xref>). In the dataset, a special parametric value, <italic>q</italic> &#x3d; 0, is the critical point of the dynamic system.</p>
<p>As shown in <xref ref-type="fig" rid="F2">Figure 2B</xref>, the ranking score increases rapidly when the regulatory network model arrives at a special parametric value, <italic>q</italic> &#x3d; 0, which is the critical point of the dynamic system. Moreover, there is a sharp increase at a parameter value <italic>q</italic> &#x3d; &#x2212;0.001, indicating the upcoming critical point at the parameter value <italic>q</italic> &#x3d; 0. Such a signal can be successfully detected by our method, which demonstrates the effectiveness of S-PCR in detecting the early warning signal of the pre-disease state.</p>
</sec>
<sec id="s3-2">
<title>Pre-disease state identification for influenza infection</title>
<p>To illustrate how S-PCR works, the proposed method was applied to two time-series influenza infections, namely, GSE30550 and GSE52428. In datasets GSE30550 and GSE52428, the data were collected from 17 and 23 human adult subjects, and their influenza virus H3N2 or H1N1 infection process was recorded (<xref ref-type="bibr" rid="B13">Huang et al., 2011</xref>; <xref ref-type="bibr" rid="B43">Woods et al., 2013</xref>), respectively. For each dataset, nine subjects developed clinical symptoms of influenza infection and were called symptomatic subjects. Others did not have clinical symptoms at all time points and were called asymptomatic subjects. For each subject, the data at the time point baseline were used to calculate the data of their time point <italic>baseline</italic>. Following the algorithm of S-PCR in <xref ref-type="sec" rid="s2">Section 2</xref>, 17 and 23 ranking scores were calculated based on all subjects at each time point for each dataset (<xref ref-type="fig" rid="F3">Figures 3A, C</xref>). The samples from all asymptomatic subjects were utilized as normal samples to determine the threshold for detecting the pre-disease state. A ranking score above the threshold indicates the imminent appearance of influenza infection symptoms.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Summarized prediction results of the two influenza virus infection datasets. <bold>(A, C)</bold> Heatmap of prediction results for datasets GSE30550 and GSE52428. <bold>(B, D)</bold> Average ranking scores across all symptomatic subjects from datasets GSE30550 and GSE52428.</p>
</caption>
<graphic xlink:href="fgene-15-1509769-g003.tif"/>
</fig>
<p>
<xref ref-type="fig" rid="F3">Figure 3A</xref> shows the ranking scores of the 17 H3N2 virus-infected subjects across the 16 time points in GSE30550 (<inline-formula id="inf31">
<mml:math id="m37">
<mml:mrow>
<mml:mi>&#x3b8;</mml:mi>
</mml:mrow>
</mml:math>
</inline-formula> &#x3d; 0.619). As shown in the figure, for each symptomatic subject, an early warning signal can be detected. All the signals are no later than the influenza infection diagnoses through the standardized symptom scoring record. Furthermore, six of nine signals are earlier than the symptom appearing; three of nine signals are detected at the same time points with the symptom appearance time. For five of eight asymptomatic subjects, no early warning signal can be detected. Furthermore, the ranking scores of the eight asymptomatic subjects are much more stable than those of the symptomatic subjects. In addition, for asymptomatic subjects 3, 16, and 17, early warning signals can be detected, which may indicate that the three subjects have symptoms after the experiment ended. <xref ref-type="fig" rid="F3">Figure 3B</xref> shows the average ranking scores across the nine symptomatic subjects. According to the average score across 16 time points, we can also predict the average time points of the early warning signal: hour 045, which is all no later than the symptom appearance time point of each symptomatic subject.</p>
<p>
<xref ref-type="fig" rid="F3">Figure 3C</xref> shows the ranking scores of the 23 H1N1 virus-infected subjects across the 16 time points in GSE52428 (<inline-formula id="inf32">
<mml:math id="m38">
<mml:mrow>
<mml:mi>&#x3b8;</mml:mi>
</mml:mrow>
</mml:math>
</inline-formula> &#x3d; 0.2). As shown in the figure, for eight of nine symptomatic subjects, the early warning signals can be successfully detected; seven early warning signals of symptomatic subjects detected by the proposed method are earlier than the symptom appearance. Only in 3 of 15 asymptomatic subjects could early warning signals be detected. The ranking scores of these asymptomatic subjects are also more stable than those of symptomatic subjects. For symptomatic subject 10, no signal can be detected by our method. This may be due to the poor data quality of the dataset. For asymptomatic subject 07, a signal can be detected because in the clinical experiment, this subject has clinical symptoms, and the total symptom score of 5 days of this subject is larger than that of some symptomatic subjects (<xref ref-type="bibr" rid="B43">Woods et al., 2013</xref>). For asymptomatic subjects 05 and 10, the signals can be detected, which may be because the noise exists in the gene expression data at the time point baseline. <xref ref-type="fig" rid="F3">Figure 3D</xref> shows the average ranking scores across the nine symptomatic subjects. According to the average score across 16 time points, we can also predict the average time points of the early warning signal, hour 045.5, which is earlier than 53&#xa0;h detected by CCs (<xref ref-type="bibr" rid="B21">Li et al., 2015</xref>), and the average time point of symptom onset at 61.3&#xa0;h (<xref ref-type="bibr" rid="B43">Woods et al., 2013</xref>).</p>
<p>The successful detection of early warning signals for the pre-disease state in datasets GSE30550 and GSE52428 by S-PCR demonstrates the effectiveness of this method in detecting the early warning signal of critical transition.</p>
</sec>
<sec id="s3-3">
<title>Pre-disease state identification for cancers</title>
<p>To further validate the effectiveness of the proposed method, the method is applied to three tumor datasets (BRCA, ESCA, and READ) from TCGA. For each dataset, the expressions of every gene are obtained by their average value across all samples at a stage. In this way, each tumor dataset can be transformed into a single-sample dataset with only one sample for each stage. For each tumor disease dataset, the tumor-adjacent samples are utilized as reference samples to calculate the data of the time point <italic>baseline</italic>. However, the number of tumor-adjacent samples in the three tumor disease datasets is small, and the gene expression data from such a tumor-adjacent sample always mix with some biological noise. Thus, a ranking score threshold is not calculated for each tumor disease dataset. The pre-disease states for the three datasets are identified through the drastic increase in the ranking scores on a continuous basis after stage I. The pre-disease states of the three datasets are identified at stage II for BRCA and ESCA and at stage IIC for READ (<xref ref-type="fig" rid="F4">Figures 4A&#x2013;C</xref>). Metastasis is the cause behind most cancer-related deaths and the ultimate challenge in our effort to fight cancer as a life-threatening disease (<xref ref-type="bibr" rid="B40">Wan et al., 2013</xref>). Stage II means the tumor cells start to spread to the nearby lymph nodes (<xref ref-type="bibr" rid="B6">Chiang and Massagu&#xe9;, 2008</xref>). These results of the proposed method are highly consistent with the actual biological processes.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Identification of the pre-disease state of tumor near metastasis in three cancers. <bold>(A&#x2013;C)</bold> Identifying the pre-disease state for <bold>(A)</bold> BRCA, <bold>(B)</bold> ESCA, and <bold>(C)</bold> READ. <bold>(D&#x2013;F)</bold> Comparing survival curves between the before the pre-disease state and after the pre-disease state in <bold>(D)</bold> BRCA, <bold>(E)</bold> ESCA, and <bold>(F)</bold> READ.</p>
</caption>
<graphic xlink:href="fgene-15-1509769-g004.tif"/>
</fig>
<p>To validate the identification of the pre-disease stage, a survival analysis is performed between the samples from different stages (<xref ref-type="fig" rid="F4">Figures 4D&#x2013;F</xref>). Compared with the samples from the stages in the disease state, the samples from the stages in normal and pre-disease states have higher life expectancy. For BRCA, <xref ref-type="fig" rid="F4">Figure 4A</xref> shows that the ranking score has a sudden increase at stages IB and II, after which the tumor cells spread to the nearby tissue (<xref ref-type="bibr" rid="B6">Chiang and Massagu&#xe9;, 2008</xref>). As shown in <xref ref-type="fig" rid="F4">Figure 4D</xref>, a significant difference (<italic>p</italic> &#x3d; 0.0006) exists between the survival curves of samples from stages I&#x2013;II and stages IIA&#x2013;X. Samples from stages I&#x2013;II have significantly longer survival periods than samples from stage IIA&#x2013;X. For ESCA, <xref ref-type="fig" rid="F4">Figure 4B</xref> shows that there is a sudden increase at stages IB and II in the ranking score. <xref ref-type="fig" rid="F4">Figure 4E</xref> shows a significant difference between the survival periods of samples in stages I&#x2013;II and stages IIA&#x2013;IVB. For READ, as shown in <xref ref-type="fig" rid="F4">Figure 4C</xref>, the drastic increase in the ranking score appears in stages IIB and IIC. <xref ref-type="fig" rid="F4">Figure 4F</xref> shows that there is a significant difference between the survival curves of samples in stages I&#x2013;IIC and samples in stages III&#x2013;IVA. These results demonstrate that S-PCR can detect the early warning signals of a critical transition of the biological process of a tumor; that is, the critical transition associated with nearby metastasis at stage II can be identified by the proposed method.</p>
</sec>
<sec id="s3-4">
<title>Functional analysis for influenza infection</title>
<p>To validate the effectiveness of the proposed ranking score, the biological process GO term enrichment analysis and KEGG pathway analysis are carried out for each dataset based on the common candidate signaling genes that appear in more than four symptomatic subjects in datasets GSE30550 and GSE52428. For each individual symptomatic subject in the datasets at the early warning signal appearing time point, the top 5% genes with the largest ranking scores are selected as candidate signaling genes.</p>
<p>For the two datasets, there are 70 and 225 common signaling genes (see <xref ref-type="sec" rid="s12">Supplementary Table S1</xref>), respectively. Based on these genes, the top five GO terms with the smallest FDR-adjusted <italic>p</italic>-values of enrichment analysis for each dataset are shown in <xref ref-type="fig" rid="F5">Figures 5A, B</xref>. The biological processes of immunity or defense against the influenza virus including &#x201c;defense response to virus,&#x201d; &#x201c;innate immune response,&#x201d; and &#x201c;response to virus&#x201d; are all ranked in the top three. The other two terms are also highly associated with the process of influenza virus infection. Interferon (IFN)-&#x3b1; can protect against influenza viral infection indirectly by promoting neutrophil respiratory burst responses (<xref ref-type="bibr" rid="B22">Little et al., 1994</xref>). Thus, the GO term &#x201c;positive regulation of interferon-alpha production&#x201d; may be highly associated with the process of influenza virus infection. Furthermore, in the lung epithelial cells, the tumor necrosis factor alpha can exert powerful anti-influenza virus effects (<xref ref-type="bibr" rid="B33">Seo and Webster, 2002</xref>). Therefore, the GO term &#x201c;tumor necrosis factor-mediated signaling pathway&#x201d; may also play an important role during influenza virus infection. The GO term &#x201c;negative regulation of viral genome replication&#x201d; is also a biological process of defense against the influenza virus. The antiviral effects of IFN-&#x3b2; against influenza virus infections are well recognized (<xref ref-type="bibr" rid="B45">Yoo et al., 2010</xref>). So, the GO term &#x201c;positive regulation of interferon-beta production&#x201d; is an important biological process during influenza virus infection. All enriched GO terms for influenza virus infection are given in <xref ref-type="sec" rid="s12">Supplementary Table S2</xref>. Clearly, the signaling genes are involved in important biological processes during influenza virus infection. Such results imply that S-PCR can also help understand the biological mechanism of influenza early infection. The common signaling genes can also be seen as the biomarker for disease early diagnosis and potential drug targets against influenza virus infection.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Results of functional analysis for the two influenza infection datasets. Top five GO terms with the smallest FDR-adjusted <italic>p</italic>-values for <bold>(A)</bold> GSE30550 and <bold>(B)</bold> GSE52428. The main direct and indirect interactions between the common and effector signaling genes in the pathway <italic>influenza A</italic> for <bold>(C)</bold> GSE30550 and <bold>(D)</bold> GSE52428.</p>
</caption>
<graphic xlink:href="fgene-15-1509769-g005.tif"/>
</fig>
<p>
<xref ref-type="fig" rid="F5">Figures 5C, D</xref> show the main direct and indirect interactions between the common and effector signaling genes (<xref ref-type="bibr" rid="B3">Bao et al., 2020</xref>) in the pathway <italic>influenza A</italic> for the two influenza infection datasets. These effector genes typically decide cell functional attributes. The functions of the genes that are both common key and effector genes are validated to be highly associated with influenza virus infection. CCL2 and CCL5 encoding proteins are included in the CC subfamily of chemokines, which are a superfamily of secreted proteins involved in immunoregulatory and inflammatory processes, and play pivotal roles in controlling leukocyte recruitment during inflammatory responses (<xref ref-type="bibr" rid="B52">Zlotnik and Yoshie, 2012</xref>). CXCL10 and IL1B encoding proteins are the pro-inflammatory cytokines that are involved in a wide variety of processes, and thereby play an important role during viral infections by stimulating the activation and migration of immune cells to the infected sites (<xref ref-type="bibr" rid="B38">Van Damme et al., 1985</xref>; <xref ref-type="bibr" rid="B2">Angiolillo et al., 1995</xref>). MX1 and MX2 encoding proteins are included in interferon-induced dynamin-like GTPase, which inhibits several different viruses by blocking the early steps of the viral replication cycle (<xref ref-type="bibr" rid="B8">Haller et al., 2015</xref>). PML proteins, the key component of subnuclear structures known as PML nuclear bodies (PML-NBs), are involved in the antiviral defense against a variety of DNA and RNA viruses (<xref ref-type="bibr" rid="B32">Scherer and Stamminger, 2016</xref>). OAS1, OAS2, and OAS3 encoding enzymes all play critical roles in cellular innate antiviral response (<xref ref-type="bibr" rid="B31">Sarkar et al., 1999</xref>; <xref ref-type="bibr" rid="B42">Wickenhagen et al., 2021</xref>).</p>
</sec>
<sec id="s3-5">
<title>Functional analysis for cancers</title>
<p>To further validate the effectiveness of the proposed ranking score, the biological process GO term enrichment and KEGG pathway analyses are also carried out for each cancer dataset based on the candidate signaling genes. For each cancer type, the top 5% genes with the largest ranking scores in the predicted pre-disease stage are selected as signaling genes (see <xref ref-type="sec" rid="s12">Supplementary Table S3</xref>).</p>
<p>The top five GO terms with the smallest FDR-adjusted <italic>p</italic>-values of enrichment analysis for each cancer dataset are shown in <xref ref-type="fig" rid="F6">Figures 6A&#x2013;C</xref>. All enriched GO terms for cancer metastasis are given in <xref ref-type="sec" rid="s12">Supplementary Table S4</xref>. The dysregulations of these biological process GO terms are highly associated with cancer. For example, the dysregulation of the mitotic spindle assembly checkpoint may cause chromosomal instability, which is a driving force for cancer development (<xref ref-type="bibr" rid="B46">Yu et al., 2022</xref>). Tumorigenesis in humans is a multistep process, which can reflect genetic alterations that drive the progressive transformation of normal cells into highly malignant derivatives, including cell differentiation and cell division (<xref ref-type="bibr" rid="B10">Hanahan and Weinberg, 2011</xref>). Gross chromosomal aberrations are usually lethal but can cause cancer (<xref ref-type="bibr" rid="B7">Curtis et al., 2020</xref>). Thus, the GO terms &#x201c;cell division,&#x201d; &#x201c;cell differentiation,&#x201d; &#x201c;mitotic cell cycle,&#x201d; &#x201c;mitotic spindle assembly checkpoint,&#x201d; &#x201c;mitotic spindle organization,&#x201d; and &#x201c;chromosome segregation&#x201d; are highly related to cancers. Many studies have elucidated that cellular adhesion processes are highly associated with cancer malignant transformation and metastasis (<xref ref-type="bibr" rid="B17">Janiszewska et al., 2020</xref>). Therefore, the GO term &#x201c;cell adhesion&#x201d; is highly associated with cancers. Cancer can be understood as a failure of multicellular systems to suppress somatic evolution (<xref ref-type="bibr" rid="B28">Nedelcu, 2020</xref>). So, the GO term &#x201c;multicellular organism development&#x201d; is related to cancers. The GO terms &#x201c;neuron projection development&#x201d; and &#x201c;positive regulation of neuron projection development&#x201d; are highly related to cancers because nerves are important pathological elements of the microenvironment of tumors (<xref ref-type="bibr" rid="B41">Wang et al., 2021</xref>). Alterations in Cu homeostasis may promote tumor growth or invasiveness, and may even confer resistance to cancer treatments (<xref ref-type="bibr" rid="B41">Wang et al., 2021</xref>). Thus, the dysregulation of the GO term &#x201c;detoxification of copper ion&#x201d; may be associated with cancers. Clearly, the signaling genes are involved in important biological processes to define the influenza virus infection. Such results imply that S-PCR can also help understand the biological mechanism of early influenza infection. The signaling genes can also be seen as the biomarker for disease early diagnosis and potential drug targets.</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Results of the functional analysis for the three cancer datasets. The top five GO terms with the smallest FDR-adjusted <italic>p</italic>-values for <bold>(A)</bold> BRCA, <bold>(B)</bold> ESCA, and <bold>(C)</bold> READ. The main interactions between the signaling genes in the pathway <italic>Focal adhesion</italic> for <bold>(D)</bold> BRCA, <bold>(E)</bold> ESCA, and <bold>(F)</bold> READ.</p>
</caption>
<graphic xlink:href="fgene-15-1509769-g006.tif"/>
</fig>
<p>Ample evidence has indicated that the <italic>focal adhesion</italic> signaling pathway can stimulate metastasis through its regulation of cell migration, invasion, and angiogenesis (<xref ref-type="bibr" rid="B29">Owen et al., 1999</xref>; <xref ref-type="bibr" rid="B11">Hauck et al., 2002</xref>; <xref ref-type="bibr" rid="B26">Luo and Guan, 2010</xref>). Thus, the <italic>focal adhesion</italic> pathway in the KEGG database is used to perform the KEGG pathway analysis for the three cancer datasets. <xref ref-type="fig" rid="F6">Figures 6D&#x2013;F</xref> show the interactions between signaling genes for each cancer type. In the KEGG database, the <italic>focal adhesion</italic> pathway mainly involves three cell functions: cell motility, cell proliferation, and cell survival. As shown in the figures, these signaling genes selected by the three cancer datasets in the <italic>focal adhesion</italic> pathway are all highly associated with cell function and cell motility, which is highly associated with tumor metastasis (<xref ref-type="bibr" rid="B36">Stuelten et al., 2018</xref>; <xref ref-type="bibr" rid="B30">Palmer et al., 2011</xref>). In general, the above results suggest that in cancer progression, abnormal cell motility would cause the uncontrolled progression of the cell cycle, ultimately causing further malignant metastasis.</p>
</sec>
<sec id="s3-6">
<title>Time complexity and running time comparison</title>
<p>The previous results of the simulated and five real datasets validated the good performance of the proposed method S-PCR in accurately identifying the pre-disease state. The results of the functional analysis also demonstrated the effectiveness of the ranking score used in this computational approach. In addition to these, profiting from the use of gene expression ranking, the time complexity and running time of S-PCR are greatly reduced compared to other methods.</p>
<p>Network and entropy-based methods always need to calculate the entropy based on complex biological networks. Furthermore, gene expression distribution-based methods need to fit the distribution comparison for thousands of genes. Thus, previous single-sample suitable methods are always complex. S-PCR only needs to acquire the expression ranking of each time point and then calculate the change in such ranking and expression value by matrix operation, which can omit such limitations. So, compared to other methods, S-PCR is a simple method. To validate the simplicity of S-PCR, the time complexity of the proposed method is compared to other methods, SLE (<xref ref-type="bibr" rid="B23">Liu et al., 2020</xref>) and sJSD (<xref ref-type="bibr" rid="B44">Yan et al., 2021</xref>), which is the classical method for the methods based on the network and gene expression distribution, respectively. If we use genomic data including total <italic>n</italic> genes to perform the three methods, the time complexity analysis of the three methods is as follows. The main step in S-PCR is the calculation of gene expression ranking using a fast sort algorithm. Thus, the time complexity of S-PCR is O(nlogn). The main step of the SLE method is the calculation of Pearson&#x2019;s correlation coefficient between the whole n genes. Thus, the time complexity of SLE is O(n<sup>2</sup>). For sJSD, the expression curve and probability for each gene should be calculated before calculating Jensen&#x2013;Shannon divergence for each gene using <italic>m</italic> normal or case samples. Therefore, the time complexity of sJSD is also O(n<sup>2</sup>).</p>
<p>Extrapolating from the result of time complexity comparison, our method should run much faster than SLE and sJSD with the same computational machine. To validate such results, the average running time for each symptomatic subject in GSE30550 of the proposed method is compared to that of the other two methods. S-PCR is performed using R 4.0.3. SLE and sJSD are performed using MATLAB 2018b. All numerical experiments are done on a Windows computer with eight Core 2.3&#xa0;GHz processors (Intel Core i7-10875H CPU) and 16&#xa0;GB of physical memory. As shown in <xref ref-type="fig" rid="F7">Figure 7</xref>, our method is implemented much faster than SLE and sJSD on the same computer. Therefore, the S-PCR method can better simplify the processes of personalized early disease prevention and promote its development.</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>Average running time of three methods for each symptomatic subject in GSE30550.</p>
</caption>
<graphic xlink:href="fgene-15-1509769-g007.tif"/>
</fig>
</sec>
<sec id="s3-7">
<title>Advantage of using gene expression ranking in S-PCR</title>
<p>By using the change in gene expression ranking, S-PCR can amplify the early warning signal just like DNA PCR amplification techniques. To validate this advantage of gene expression ranking change, the gene expression value is compared with the ranking score. <xref ref-type="fig" rid="F8">Figure 8</xref> shows the normalized gene expression values and ranking scores of symptomatic subject 01 across 70 common signaling genes for dataset GSE30550.</p>
<fig id="F8" position="float">
<label>FIGURE 8</label>
<caption>
<p>Normalized gene expression values and rank scores of 70 common signaling genes for subject 01 in GSE30550.</p>
</caption>
<graphic xlink:href="fgene-15-1509769-g008.tif"/>
</fig>
<p>The gene expression value and ranking score are all normalized in a similar way to make the comparison at the same level. For a common signaling gene <inline-formula id="inf33">
<mml:math id="m39">
<mml:mrow>
<mml:msub>
<mml:mi>k</mml:mi>
<mml:mi>J</mml:mi>
</mml:msub>
</mml:mrow>
</mml:math>
</inline-formula>, the normalized gene expression value and ranking score are normalized by the minimum value across all common signaling genes, as <xref ref-type="disp-formula" rid="e7">Formula 7</xref> shown.<disp-formula id="e7">
<mml:math id="m40">
<mml:mrow>
<mml:mo>&#x394;</mml:mo>
<mml:msub>
<mml:mi>V</mml:mi>
<mml:mi>j</mml:mi>
</mml:msub>
<mml:mo>&#x3d;</mml:mo>
<mml:mfrac>
<mml:msub>
<mml:mi>V</mml:mi>
<mml:mi>j</mml:mi>
</mml:msub>
<mml:mrow>
<mml:mi mathvariant="italic">min</mml:mi>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="&#x7c;">
<mml:mrow>
<mml:msub>
<mml:mi>V</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo>,</mml:mo>
<mml:msub>
<mml:mi>V</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mo>,</mml:mo>
<mml:mo>&#x22ef;</mml:mo>
<mml:mo>,</mml:mo>
<mml:msub>
<mml:mi>V</mml:mi>
<mml:mn>70</mml:mn>
</mml:msub>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
</mml:mrow>
</mml:mfrac>
<mml:mo>,</mml:mo>
</mml:mrow>
</mml:math>
<label>(7)</label>
</disp-formula>where <inline-formula id="inf34">
<mml:math id="m41">
<mml:mrow>
<mml:mo>&#x394;</mml:mo>
<mml:msub>
<mml:mi>V</mml:mi>
<mml:mi>j</mml:mi>
</mml:msub>
</mml:mrow>
</mml:math>
</inline-formula> is the normalized gene expression value or ranking score of the common signaling gene <inline-formula id="inf35">
<mml:math id="m42">
<mml:mrow>
<mml:msub>
<mml:mi>k</mml:mi>
<mml:mi>j</mml:mi>
</mml:msub>
</mml:mrow>
</mml:math>
</inline-formula>. <inline-formula id="inf36">
<mml:math id="m43">
<mml:mrow>
<mml:msub>
<mml:mi>V</mml:mi>
<mml:mi>j</mml:mi>
</mml:msub>
</mml:mrow>
</mml:math>
</inline-formula> is the original gene expression value or ranking score of the gene <inline-formula id="inf37">
<mml:math id="m44">
<mml:mrow>
<mml:msub>
<mml:mi>k</mml:mi>
<mml:mi>j</mml:mi>
</mml:msub>
</mml:mrow>
</mml:math>
</inline-formula>. <inline-formula id="inf38">
<mml:math id="m45">
<mml:mrow>
<mml:msub>
<mml:mi>V</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo>,</mml:mo>
<mml:msub>
<mml:mi>V</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mo>,</mml:mo>
<mml:mo>&#x22ef;</mml:mo>
<mml:mo>,</mml:mo>
<mml:msub>
<mml:mi>V</mml:mi>
<mml:mn>70</mml:mn>
</mml:msub>
</mml:mrow>
</mml:math>
</inline-formula> are the gene expression values or ranking scores of the 70 common signaling genes, respectively.</p>
<p>As the figure shows, the normalized ranking scores for most common signaling genes are much more than their normalized gene expression values. Such a result indicates that the usage of gene expression ranking can amplify the early warning signal.</p>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>Detecting the pre-disease state is of great importance to signal the upcoming disease, which is helpful for the development of disease prevention and ultra-early precision treatment. Chen et al. proposed the DNB method to predict the pre-disease state (<xref ref-type="bibr" rid="B5">Chen et al., 2012</xref>; <xref ref-type="bibr" rid="B24">Liu et al., 2012</xref>). However, this method needs to select a small group of molecules using three measurements, including the calculation of Pearson&#x2019;s correlation coefficient and standard deviation, which need multiple samples at each time point. In clinical practice, only one sample can be gained at each time point. Thus, the DNB method is unsuitable for clinical single-sample datasets. In this study, we propose a novel pre-disease state prediction method based on the ranking change in gene expression following the DNB theory, which is suitable for single-sample datasets, called S-PCR. A simulated dataset, two influenza virus infection datasets, and three TCGA cancer datasets are used to measure the performance of the proposed method. The results are consistent with those of the clinical and experimental observations. For the six datasets, only one symptomatic subject from dataset GSE52428 could not be found during the pre-disease state. Furthermore, the signaling genes detected by S-PCR for the five real disease datasets are always highly related to the pre-disease state-related biological processes and cell functions. Thus, the accuracy of S-PCR is competitive. Furthermore, the time efficiency of S-PCR is also validated by comparing with other methods. Furthermore, using the gene expression ranking change in S-PCR can help us better identify gene expression fluctuating signals at the pre-disease state.</p>
<p>Additionally, S-PCR is a gene expression fluctuating signal-sensitive approach. The pre-disease state is always defined as the limit of the normal state. Thus, the expression value of a gene at the pre-disease state may have little/no difference from that at the normal state. However, the expression ranking of the gene may have a bigger change from the pre-disease to the normal state. On the other hand, if the expression values of whole genes in the system are all changed at the same time, the gene expression rankings of these genes may have little/no changes. From these aspects, the proposed S-PCR can remove some noises in gene expression data and is a gene expression-fluctuating signal-sensitive approach.</p>
<p>However, we should point out that using gene expression ranking may introduce some noises for that there are no interactions between some genes with huge changes in the expression ranking. In the future, there are two ways to solve this problem. First, the credible small-scale functional gene regulatory networks or relevant key regulatory targets, which are identified to be highly associated with the initial progression of complex diseases, can be introduced instead of the whole genome (<xref ref-type="bibr" rid="B48">Zhenshen et al., 2023</xref>; <xref ref-type="bibr" rid="B18">Jin et al., 2023</xref>). This is because the genes in these sets always interact strongly with each other. Second, energy landscape theory can be used to amplify abnormal signals and minimize the impact of noise. Thus, the expression ranking change can be further combined with the energy landscape theory (<xref ref-type="bibr" rid="B19">Jin et al., 2024</xref>).</p>
</sec>
<sec sec-type="conclusion" id="s5">
<title>Conclusion</title>
<p>In this paper, a method called S-PCR to rapidly identify the pre-disease state of complex diseases for a single sample is presented. S-PCR obtains a set of DNBs by using the change in gene expression ranking. Benefiting from the use of gene expression ranking, the calculation performed using the S-PCR method takes much less time than that performed using other methods. Therefore, S-PCR can accurately identify the pre-disease state in less time than other methods. Hence, the S-PCR method has great potential in clinical early prevention medicine.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s6">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s12">Supplementary Material</xref>; further inquiries can be directed to the corresponding authors.</p>
</sec>
<sec sec-type="author-contributions" id="s7">
<title>Author contributions</title>
<p>ZB: funding acquisition, investigation, methodology, validation, visualization, writing&#x2013;original draft, and writing&#x2013;review and editing. XL: funding acquisition, methodology, validation, and writing&#x2013;review and editing. PX: funding acquisition, methodology, visualization, and writing&#x2013;review and editing. XZ: data curation, investigation, methodology, supervision, validation, visualization, and writing&#x2013;review and editing.</p>
</sec>
<sec sec-type="funding-information" id="s8">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was funded in part by the National Natural Science Foundation of China (grant nos. 62102104, 62202115, and 62002079). The funding agency provided funds for the article processing fees but had no role in study design, data collection, analysis, interpretation, or manuscript preparation.</p>
</sec>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="s11">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
</sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors, and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s12">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fgene.2024.1509769/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fgene.2024.1509769/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Table2.xlsx" id="SM1" mimetype="application/xlsx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table3.xlsx" id="SM2" mimetype="application/xlsx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table4.xlsx" id="SM3" mimetype="application/xlsx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table1.xlsx" id="SM4" mimetype="application/xlsx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Achiron</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Grotto</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Balicer</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Magalashvili</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Feldman</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gurevich</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Microarray analysis identifies altered regulation of nuclear receptor family members in the pre-disease state of multiple sclerosis</article-title>. <source>Neurobiol. Dis.</source> <volume>38</volume>, <fpage>201</fpage>&#x2013;<lpage>209</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2009.12.029</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Angiolillo</surname>
<given-names>A. L.</given-names>
</name>
<name>
<surname>Sgadari</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Taub</surname>
<given-names>D. D.</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Farber</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Maheshwari</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>1995</year>). <article-title>Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis <italic>in vivo</italic>
</article-title>. <source>J. Exp. Med.</source> <volume>182</volume>, <fpage>155</fpage>&#x2013;<lpage>162</lpage>. <pub-id pub-id-type="doi">10.1084/jem.182.1.155</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bao</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ge</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Bai</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Identifying disease-associated signaling pathways through a novel effector gene analysis</article-title>. <source>PeerJ</source> <volume>8</volume>, <fpage>e9695</fpage>. <pub-id pub-id-type="doi">10.7717/peerj.9695</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bao</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Huo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>A simple pre-disease state prediction method based on variations of gene vector features</article-title>. <source>Comput. Biol. Med.</source> <volume>148</volume>, <fpage>105890</fpage>. <pub-id pub-id-type="doi">10.1016/j.compbiomed.2022.105890</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z. P.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Aihara</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Detecting early-warning signals for sudden deterioration of complex diseases by dynamical network biomarkers</article-title>. <source>Sci. Rep.</source> <volume>2</volume>, <fpage>342</fpage>. <pub-id pub-id-type="doi">10.1038/srep00342</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chiang</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Massagu&#xe9;</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Molecular basis of metastasis</article-title>. <source>N. Engl. J. Med.</source> <volume>359</volume>, <fpage>2814</fpage>&#x2013;<lpage>2823</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMra0805239</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Curtis</surname>
<given-names>N. L.</given-names>
</name>
<name>
<surname>Ruda</surname>
<given-names>G. F.</given-names>
</name>
<name>
<surname>Brennan</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Bolanos-Garcia</surname>
<given-names>V. M.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Deregulation of chromosome segregation and cancer</article-title>. <source>Annu. Rev. Cancer Biol.</source> <volume>4</volume>, <fpage>257</fpage>&#x2013;<lpage>278</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-cancerbio-030419-033541</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haller</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Staeheli</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Schwemmle</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kochs</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Mx GTPases: dynamin-like antiviral machines of innate immunity</article-title>. <source>Trends Microbiol.</source> <volume>23</volume>, <fpage>154</fpage>&#x2013;<lpage>163</lpage>. <pub-id pub-id-type="doi">10.1016/j.tim.2014.12.003</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ling</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Single-sample node entropy for molecular transition in pre-deterioration stage of cancer</article-title>. <source>Front. Bioeng. Biotechnol.</source> <volume>8</volume>, <fpage>809</fpage>. <pub-id pub-id-type="doi">10.3389/fbioe.2020.00809</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hanahan</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Weinberg</surname>
<given-names>R. A.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Hallmarks of cancer: the next generation</article-title>. <source>Cell</source> <volume>144</volume>, <fpage>646</fpage>&#x2013;<lpage>674</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2011.02.013</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hauck</surname>
<given-names>C. R.</given-names>
</name>
<name>
<surname>Hsia</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Puente</surname>
<given-names>X. S.</given-names>
</name>
<name>
<surname>Cheresh</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Schlaepfer</surname>
<given-names>D. D.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>FRNK blocks v-Src-stimulated invasion and experimental metastases without effects on cell motility or growth</article-title>. <source>Embo J.</source> <volume>21</volume>, <fpage>6289</fpage>&#x2013;<lpage>6302</lpage>. <pub-id pub-id-type="doi">10.1093/emboj/cdf631</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hong</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Tong</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Edge-based relative entropy as a sensitive indicator of critical transitions in biological systems</article-title>. <source>J. Transl. Med.</source> <volume>22</volume>, <fpage>333</fpage>. <pub-id pub-id-type="doi">10.1186/s12967-024-05145-3</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zaas</surname>
<given-names>A. K.</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Dobigeon</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Woolf</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Veldman</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Temporal dynamics of host molecular responses differentiate symptomatic and asymptomatic influenza a infection</article-title>. <source>PLoS Genet.</source> <volume>7</volume>, <fpage>e1002234</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1002234</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang da</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Sherman</surname>
<given-names>B. T.</given-names>
</name>
<name>
<surname>Lempicki</surname>
<given-names>R. A.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources</article-title>. <source>Nat. Protoc.</source> <volume>4</volume>, <fpage>44</fpage>&#x2013;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2008.211</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Bao</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Detecting early-warning signals for influenza by dysregulated dynamic network biomarkers</article-title>. <source>Brief. Funct. Genomics</source> <volume>22</volume>, <fpage>366</fpage>&#x2013;<lpage>374</lpage>. <pub-id pub-id-type="doi">10.1093/bfgp/elad006</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ruan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Detect the early-warning signals of diseases based on signaling pathway perturbations on a single sample</article-title>. <source>BMC Bioinforma.</source> <volume>22</volume>, <fpage>367</fpage>. <pub-id pub-id-type="doi">10.1186/s12859-021-04286-2</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Janiszewska</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Primi</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Izard</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Cell adhesion in cancer: beyond the migration of single cells</article-title>. <source>J. Biol. Chem.</source> <volume>295</volume>, <fpage>2495</fpage>&#x2013;<lpage>2505</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.REV119.007759</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Xiang</surname>
</name>
<name>
<surname>Yao</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Shuai</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Biphasic amplitude oscillator characterized by distinct dynamics of trough and crest</article-title>. <source>Phys. Rev. E</source> <volume>108</volume>, <fpage>064412</fpage>. <pub-id pub-id-type="doi">10.1103/PhysRevE.108.064412</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Shuai</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Quantifying the underlying landscape, entropy production and biological path of the cell fate decision between apoptosis and pyroptosis</article-title>. <source>Chaos, Solit. and Fractals</source> <volume>178</volume>, <fpage>114328</fpage>. <pub-id pub-id-type="doi">10.1016/j.chaos.2023.114328</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kanehisa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Furumichi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Matsuura</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ishiguro-Watanabe</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>KEGG: biological systems database as a model of the real world</article-title>. <source>Nucleic Acids Res.</source>, <fpage>gkae909</fpage>. <pub-id pub-id-type="doi">10.1093/nar/gkae909</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Deciphering deterioration mechanisms of complex diseases based on the construction of dynamic networks and systems analysis</article-title>. <source>Sci. Rep.</source> <volume>5</volume>, <fpage>9283</fpage>. <pub-id pub-id-type="doi">10.1038/srep09283</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Little</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>White</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Hartshorn</surname>
<given-names>K. L.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>Interferon-alpha enhances neutrophil respiratory burst responses to stimulation with influenza A virus and FMLP</article-title>. <source>J. Infect. Dis.</source> <volume>170</volume>, <fpage>802</fpage>&#x2013;<lpage>810</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/170.4.802</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Single-sample landscape entropy reveals the imminent phase transition during disease progression</article-title>. <source>Bioinformatics</source> <volume>36</volume>, <fpage>1522</fpage>&#x2013;<lpage>1532</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btz758</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z. P.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Aihara</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Identifying critical transitions and their leading biomolecular networks in complex diseases</article-title>. <source>Sentific Rep.</source> <volume>2</volume>, <fpage>813</fpage>. <pub-id pub-id-type="doi">10.1038/srep00813</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Aihara</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Identifying critical transitions of complex diseases based on a single sample</article-title>. <source>Bioinformatics</source> <volume>30</volume>, <fpage>1579</fpage>&#x2013;<lpage>1586</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btu084</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>J. L.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Focal adhesion kinase: a prominent determinant in breast cancer initiation, progression and metastasis</article-title>. <source>Cancer Lett.</source> <volume>289</volume>, <fpage>127</fpage>&#x2013;<lpage>139</lpage>. <pub-id pub-id-type="doi">10.1016/j.canlet.2009.07.005</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McSharry</surname>
<given-names>P. E.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>L. A.</given-names>
</name>
<name>
<surname>Tarassenko</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Prediction of epileptic seizures: are nonlinear methods relevant?</article-title>. <source>Nat. Med.</source> <volume>9</volume>, <fpage>241</fpage>&#x2013;<lpage>242</lpage>. <pub-id pub-id-type="doi">10.1038/nm0303-241</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nedelcu</surname>
<given-names>A. M.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The evolution of multicellularity and cancer: views and paradigms</article-title>. <source>Biochem. Soc. Trans.</source> <volume>48</volume>, <fpage>1505</fpage>&#x2013;<lpage>1518</lpage>. <pub-id pub-id-type="doi">10.1042/BST20190992</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Owen</surname>
<given-names>J. D.</given-names>
</name>
<name>
<surname>Ruest</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Fry</surname>
<given-names>D. W.</given-names>
</name>
<name>
<surname>Hanks</surname>
<given-names>S. K.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Induced focal adhesion kinase (FAK) expression in FAK-null cells enhances cell spreading and migration requiring both auto- and activation loop phosphorylation sites and inhibits adhesion-dependent tyrosine phosphorylation of Pyk2</article-title>. <source>Mol. Cell Biol.</source> <volume>19</volume>, <fpage>4806</fpage>&#x2013;<lpage>4818</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.19.7.4806</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palmer</surname>
<given-names>T. D.</given-names>
</name>
<name>
<surname>Ashby</surname>
<given-names>W. J.</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>J. D.</given-names>
</name>
<name>
<surname>Zijlstra</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Targeting tumor cell motility to prevent metastasis</article-title>. <source>Adv. Drug Deliv. Rev.</source> <volume>63</volume>, <fpage>568</fpage>&#x2013;<lpage>581</lpage>. <pub-id pub-id-type="doi">10.1016/j.addr.2011.04.008</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sarkar</surname>
<given-names>S. N.</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H. W.</given-names>
</name>
<name>
<surname>Sung</surname>
<given-names>S. S.</given-names>
</name>
<name>
<surname>Sen</surname>
<given-names>G. C.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>The nature of the catalytic domain of 2&#x27;-5&#x27;-oligoadenylate synthetases</article-title>. <source>J. Biol. Chem.</source> <volume>274</volume>, <fpage>25535</fpage>&#x2013;<lpage>25542</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.274.36.25535</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scherer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Stamminger</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Emerging role of PML nuclear bodies in innate immune signaling</article-title>. <source>J. Virol.</source> <volume>90</volume>, <fpage>5850</fpage>&#x2013;<lpage>5854</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.01979-15</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seo</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Webster</surname>
<given-names>R. G.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Tumor necrosis factor alpha exerts powerful anti-influenza virus effects in lung epithelial cells</article-title>. <source>J. virology</source> <volume>76</volume>, <fpage>1071</fpage>&#x2013;<lpage>1076</lpage>. <pub-id pub-id-type="doi">10.1128/jvi.76.3.1071-1076.2002</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sherman</surname>
<given-names>B. T.</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jiao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Baseler</surname>
<given-names>M. W.</given-names>
</name>
<name>
<surname>Lane</surname>
<given-names>H. C.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update)</article-title>. <source>Nucleic Acids Res.</source> <volume>50</volume>, <fpage>W216</fpage>&#x2013;<lpage>w221</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkac194</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Srinivasan</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>A guide to the Michaelis-Menten equation: steady state and beyond</article-title>. <source>Febs J.</source> <volume>289</volume>, <fpage>6086</fpage>&#x2013;<lpage>6098</lpage>. <pub-id pub-id-type="doi">10.1111/febs.16124</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stuelten</surname>
<given-names>C. H.</given-names>
</name>
<name>
<surname>Parent</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Montell</surname>
<given-names>D. J.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Cell motility in cancer invasion and metastasis: insights from simple model organisms</article-title>. <source>Nat. Rev. Cancer</source> <volume>18</volume>, <fpage>296</fpage>&#x2013;<lpage>312</lpage>. <pub-id pub-id-type="doi">10.1038/nrc.2018.15</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Subramanian</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tamayo</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mootha</surname>
<given-names>V. K.</given-names>
</name>
<name>
<surname>Mukherjee</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ebert</surname>
<given-names>B. L.</given-names>
</name>
<name>
<surname>Gillette</surname>
<given-names>M. A.</given-names>
</name>
<etal/>
</person-group> (<year>2005</year>). <article-title>Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles</article-title>. <source>Proc. Natl. Acad. Sci.</source> <volume>102</volume>, <fpage>15545</fpage>&#x2013;<lpage>15550</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0506580102</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Damme</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>De Ley</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Opdenakker</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Billiau</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>De Somer</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Van Beeumen</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>1985</year>). <article-title>Homogeneous interferon-inducing 22K factor is related to endogenous pyrogen and interleukin-1</article-title>. <source>Nature</source> <volume>314</volume>, <fpage>266</fpage>&#x2013;<lpage>268</lpage>. <pub-id pub-id-type="doi">10.1038/314266a0</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Venegas</surname>
<given-names>J. G.</given-names>
</name>
<name>
<surname>Winkler</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Musch</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Vidal Melo</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Layfield</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Tgavalekos</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2005</year>). <article-title>Self-organized patchiness in asthma as a prelude to catastrophic shifts</article-title>. <source>Nature</source> <volume>434</volume>, <fpage>777</fpage>&#x2013;<lpage>782</lpage>. <pub-id pub-id-type="doi">10.1038/nature03490</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Pantel</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Tumor metastasis: moving new biological insights into the clinic</article-title>. <source>Nat. Med.</source> <volume>19</volume>, <fpage>1450</fpage>&#x2013;<lpage>1464</lpage>. <pub-id pub-id-type="doi">10.1038/nm.3391</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Role of the nervous system in cancers: a review</article-title>. <source>Cell Death Discov.</source> <volume>7</volume>, <fpage>76</fpage>. <pub-id pub-id-type="doi">10.1038/s41420-021-00450-y</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wickenhagen</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sugrue</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Lytras</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kuchi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Noerenberg</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Turnbull</surname>
<given-names>M. L.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>A prenylated dsRNA sensor protects against severe COVID-19</article-title>. <source>Science</source> <volume>374</volume>, <fpage>eabj3624</fpage>. <pub-id pub-id-type="doi">10.1126/science.abj3624</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Woods</surname>
<given-names>C. W.</given-names>
</name>
<name>
<surname>McClain</surname>
<given-names>M. T.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zaas</surname>
<given-names>A. K.</given-names>
</name>
<name>
<surname>Nicholson</surname>
<given-names>B. P.</given-names>
</name>
<name>
<surname>Varkey</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>A host transcriptional signature for presymptomatic detection of infection in humans exposed to influenza H1N1 or H3N2</article-title>. <source>PLoS One</source> <volume>8</volume>, <fpage>e52198</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0052198</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Identifying critical states of complex diseases by single-sample jensen-shannon divergence</article-title>. <source>Front. Oncol.</source> <volume>11</volume>, <fpage>684781</fpage>. <pub-id pub-id-type="doi">10.3389/fonc.2021.684781</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoo</surname>
<given-names>J. K.</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>D. P.</given-names>
</name>
<name>
<surname>Fish</surname>
<given-names>E. N.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Interferon-&#x3b2; modulates type 1 immunity during influenza virus infection</article-title>. <source>Antivir. Res.</source> <volume>88</volume>, <fpage>64</fpage>&#x2013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1016/j.antiviral.2010.07.006</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Lang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hsu</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W. M.</given-names>
</name>
<name>
<surname>Chiang</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Hsieh</surname>
<given-names>J. T.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Mitotic phosphorylation of tumor suppressor DAB2IP maintains spindle assembly checkpoint and chromosomal stability through activating PLK1-Mps1 signal pathway and stabilizing mitotic checkpoint complex</article-title>. <source>Oncogene</source> <volume>41</volume>, <fpage>489</fpage>&#x2013;<lpage>501</lpage>. <pub-id pub-id-type="doi">10.1038/s41388-021-02106-8</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Individual-specific edge-network analysis for disease prediction</article-title>. <source>Nucleic Acids Res.</source> <volume>45</volume>, <fpage>e170</fpage>. <pub-id pub-id-type="doi">10.1093/nar/gkx787</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhenshen</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Minzhen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wanqi</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Huo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>A pan-cancer analysis reveals the tissue specificity and prognostic impact of angiogenesis-associated genes in human cancers</article-title>. <source>Curr. Bioinforma.</source> <volume>18</volume>, <fpage>670</fpage>&#x2013;<lpage>679</lpage>. <pub-id pub-id-type="doi">10.2174/1574893618666230518163353</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhong</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>SPNE: sample-perturbed network entropy for revealing critical states of complex biological systems</article-title>. <source>Brief. Bioinform</source> <volume>24</volume>, <fpage>bbad028</fpage>. <pub-id pub-id-type="doi">10.1093/bib/bbad028</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhong</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Identifying the critical state of complex biological systems by the directed-network rank score method</article-title>. <source>Bioinformatics</source> <volume>38</volume>, <fpage>5398</fpage>&#x2013;<lpage>5405</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btac707</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhong</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Identifying critical state of complex diseases by single-sample Kullback-Leibler divergence</article-title>. <source>BMC genomics</source> <volume>21</volume>, <fpage>87</fpage>. <pub-id pub-id-type="doi">10.1186/s12864-020-6490-7</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zlotnik</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yoshie</surname>
<given-names>O.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>The chemokine superfamily revisited</article-title>. <source>Immunity</source> <volume>36</volume>, <fpage>705</fpage>&#x2013;<lpage>716</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2012.05.008</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>